+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hepatoprotection in ethynylestradiol-treated rats in provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid



Hepatoprotection in ethynylestradiol-treated rats in provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid



Hepatology 18(4 Part 2): 311A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031676332

Download citation: RISBibTeXText


Related references

Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid. Journal Of Gastroenterology & Hepatology. 10(3): 261-269, 1995

Ursodeoxycholic acid and not tauroursodeoxycholic acid prevents the ethynylestradiol induced intrahepatic cholestasis in rats. Gastroenterology 98(5 Part 2): A651, 1990

Ursodeoxycholic acid and tauroursodeoxycholic acid suppress choroidal neovascularization in a laser-treated rat model. Journal of Ocular Pharmacology and Therapeutics 26(3): 223-229, 2010

Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid composition in rats. Biochemical & Biophysical Research Communications. 220(3): 479-483, 1996

Toxicity of ethanol and acetaldehyde in hepatocytes treated with ursodeoxycholic or tauroursodeoxycholic acid. Biochimica et Biophysica Acta 1644(1): 37-45, 2004

Ursodeoxycholic acid versus tauroursodeoxycholic acid Crossover study of their absorption and biliary enrichment in man. Hepatology 24(4 Part 2): 372A, 1996

Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes. Plos One 8(12): E82086, 2014

Tauroursodeoxycholic acid, ursodeoxycholic acid and gallbladder motility in gallstone patients and healthy subjects. Italian Journal of Gastroenterology 28(2): 111-113, 1996

Neither ursodeoxycholic acid nor tauroursodeoxycholic acid protects rabbit hepatocytes from toxic bile acids. Gastroenterology 98(5 Part 2): A600, 1990

Pentoxifylline, but not ursodeoxycholic acid or tauroursodeoxycholic acid inhibits the proliferative effect of sera samples from primary biliary cirrhosis patients. Hepatology Research 7(2): 94-104, 1997

D22-ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial b-oxidation as a major pathway for bile acid metabolism. Biochemistry (American Chemical Society) 34: 69-78, 1995

DELTA-22-ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism. Biochemistry. 34(13): 4169-4178, 1995

Clinical evidence of hepatoprotection induced by ursodeoxycholic acid. Acta Physiologica Hungarica 80(1-4): 369-374, 1992

Mechanisms of cell injury and death in cholestasis and hepatoprotection by ursodeoxycholic acid. Journal of Hepatology 32(Suppl. 2): 11-13, 2000

Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis. Advances in Medical Sciences 51: 54-59, 2007